The Main Decision-making Competence for Willingness-to-pay Towards COVID-19 Vaccination: a Family-based Study in Taizhou, China

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2022 Aug 25

PMID 36004802

Authors

Chengwen Luo

Mei-Xian Zhang

Eva Jiang

Mindan Jin

Tao-Hsin Tung

Jian-Sheng Zhu

Affiliations

Soon will be listed here.

Abstract

Purpose: This research aimed to explore individuals' willingness to pay (WTP) and studied the role of family decision makers in WTP for COVID-19 vaccines.

Methods: A self-administered online questionnaire evaluating the willingness of community residents to pay for booster vaccination of COVID-19 vaccine was conducted among families in a community in Taizhou, China. The logistic regression model was performed to identify the factors associated with WTP for the COVID-19 vaccines, and all data were analysed by R software, version 4.1.0.

Results: 44.2% and 43.7% of 824 community residents were willing to pay for the first two doses and the booster dose of the COVID-19 vaccine, respectively. Decision-makers were more willing to pay for both the first two doses and the boost dose of the COVID-19 vaccines, with OR (95%CI) being 1.75 (1.25-2.47) and 1.89 (1.34-2.67), respectively. Besides, participants' WTP for COVID-19 vaccines were also associated with their occupation and monthly household income.

Conclusion: This study found that family decision-makers were more willing to pay for both the first two doses and the booster dose of COVID-19 vaccines in Taizhou, China. To improve the WTP for COVID-19 vaccines, public policy programs need to conduct a comprehensive cost-benefit analysis and focus on the role of family decision makers in vaccination.Key MessagesA study evaluating the willingness of community residents to pay for booster vaccination of COVID-19 vaccine was conducted among families in a community in Taizhou, China.Family decision-makers were more willing to pay for both the first two doses and the booster dose of COVID-19 vaccines.To improve the WTP for COVID-19 vaccines, public policy programs need to conduct a comprehensive cost-benefit analysis and focus on the role of family decision-makers in vaccination.

Citing Articles

Hesitation towards COVID-19 booster vaccination among dialysis patients: a cross-sectional study in Taizhou, China.

Luo C, Tung T, Zhu J BMC Infect Dis. 2024; 24(1):1095.

PMID: 39358705 PMC: 11445873. DOI: 10.1186/s12879-024-09917-6.

Impact of household decision makers' hesitancy to vaccinate children against COVID-19 on other household members: A family-based study in Taizhou, China.

Deng J, Ying C, Lin X, Huang C, Zhang M, Tung T SSM Popul Health. 2023; 24:101517.

PMID: 37767519 PMC: 10520923. DOI: 10.1016/j.ssmph.2023.101517.

COVID-19 vaccine hesitancy between family decision-makers and non-decision-makers among college teachers.

Xu R, Shi G, Zheng S, Tung T, Zhang M Ann Med. 2023; 55(1):292-304.

PMID: 36594480 PMC: 9815219. DOI: 10.1080/07853890.2022.2162114.

References

Sallam M, Anwar S, Yufika A, Fahriani M, Husnah M, Kusuma H . Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study. Narra J. 2024; 2(1):e74. PMC: 10914042. DOI: 10.52225/narra.v2i1.74. View

Feng S, Shen C, Xia N, Song W, Fan M, Cowling B . Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med. 2020; 8(5):434-436. PMC: 7118603. DOI: 10.1016/S2213-2600(20)30134-X. View

Ryan M, Scott D, Reeves C, Bate A, van Teijlingen E, Russell E . Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001; 5(5):1-186. DOI: 10.3310/hta5050. View

Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H . Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020; 13(5):667-673. PMC: 7142680. DOI: 10.1016/j.jiph.2020.03.019. View

Harapan H, Wagner A, Yufika A, Winardi W, Anwar S, Gan A . Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccin Immunother. 2020; 16(12):3074-3080. PMC: 8641577. DOI: 10.1080/21645515.2020.1819741. View

Eikenberry S, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y . To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model. 2020; 5:293-308. PMC: 7186508. DOI: 10.1016/j.idm.2020.04.001. View

Hou Z, Chang J, Yue D, Fang H, Meng Q, Zhang Y . Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014; 32(35):4471-4477. DOI: 10.1016/j.vaccine.2014.06.047. View

Sendi P, Ramadani A, Zitzmann N, Bornstein M . A Systematic Review of WTA-WTP Disparity for Dental Interventions and Implications for Cost-Effectiveness Analysis. Healthcare (Basel). 2020; 8(3). PMC: 7550993. DOI: 10.3390/healthcare8030301. View

Rajamoorthy Y, Radam A, Mohd Taib N, Rahim K, Munusamy S, Wagner A . Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey. PLoS One. 2019; 14(4):e0215125. PMC: 6456223. DOI: 10.1371/journal.pone.0215125. View

10.

Shih H, Chou P, Chen S, Liu J, Lee F, Liu C . A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan. J Epidemiol. 2007; 17(6):186-93. PMC: 7058465. DOI: 10.2188/jea.17.186. View

11.

Tung T, Lin X, Chen Y, Wu H, Zhang M, Zhu J . Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China. Hum Vaccin Immunother. 2022; 18(1):1-9. PMC: 8920241. DOI: 10.1080/21645515.2021.2014731. View

12.

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

13.

Palanca-Tan R . The demand for a dengue vaccine: a contingent valuation survey in Metro Manila. Vaccine. 2008; 26(7):914-23. DOI: 10.1016/j.vaccine.2007.12.011. View

14.

Cerda A, Garcia L . Willingness to Pay for a COVID-19 Vaccine. Appl Health Econ Health Policy. 2021; 19(3):343-351. PMC: 7899739. DOI: 10.1007/s40258-021-00644-6. View

15.

Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H . Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021; 39(14):1968-1976. PMC: 7914003. DOI: 10.1016/j.vaccine.2021.02.060. View

16.

Nguyen L, Hoang M, Nguyen L, Ninh L, Nguyen H, Nguyen A . Acceptance and willingness to pay for COVID-19 vaccines among pregnant women in Vietnam. Trop Med Int Health. 2021; 26(10):1303-1313. PMC: 8447150. DOI: 10.1111/tmi.13666. View

17.

Hadisoemarto P, Castro M . Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. PLoS Negl Trop Dis. 2013; 7(9):e2427. PMC: 3777870. DOI: 10.1371/journal.pntd.0002427. View

18.

Hao F, Wang B, Tan W, Husain S, McIntyre R, Tang X . Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China. BJPsych Open. 2021; 7(5):e146. PMC: 8365102. DOI: 10.1192/bjo.2021.979. View

19.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

20.

Qin W, Wang E, Ni Z . Chinese consumers' willingness to get a COVID-19 vaccine and willingness to pay for it. PLoS One. 2021; 16(5):e0250112. PMC: 8096001. DOI: 10.1371/journal.pone.0250112. View